transcatheter mitral valve

Más evidencia positiva para tratar prótesis biológicas disfuncionantes con la prótesis balón expandible

Further Evidence on Managing Dysfunctioning Bioprostheses with Balloon-Expandable Prostheses

Early experience with the valve-in-valve technique in the treatment of failed bioprosthetic surgical valves in transcatheter aortic valve replacement (TAVR) has yielded acceptable acute procedural results. This turned the technique into another therapeutic option, one that could even cause the reassessment of the age limit for the surgical implantation of a mechanical or bioprosthesis valve.<a href="https://solaci.org/en/2017/05/17/further-evidence-on-managing-dysfunctioning-bioprostheses-with-balloon-expandable-prostheses/" title="Read more" >...</a>

Trombólisis local en tromboembolismo pulmonar

Diastolic Dysfunction: Shall We Begin to Assess It?

Courtesy of Dr. Carlos&nbsp;Fava. The association between diastolic dysfunction (DD) and aortic insufficiency (AI) after transcatheter aortic valve replacement (TAVR) has not been studied yet, but the presence of aortic regurgitation has proved to be associated with worse outcomes. &nbsp; A total of 144 out of 195&nbsp;patients who underwent TAVR with balloon-expandable SAPIENS or SAPIENS&nbsp;XT<a href="https://solaci.org/en/2017/04/19/diastolic-dysfunction-shall-we-begin-to-assess-it/" title="Read more" >...</a>

tavr insuficiencia aórtica pura

TAVR in Pure Aortic Insufficiency: Yes or No?

Courtesy of Dr.&nbsp;Agustín&nbsp;Vecchia. Surgery is the treatment of choice for patients with symptomatic aortic insufficiency and/or ventricular dilatation or decreased ventricular function. The broad implementation of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis, the emergence of new devices, and the experience acquired by operators have brought this treatment to off-label indications such<a href="https://solaci.org/en/2016/12/13/tavr-in-pure-aortic-insufficiency/" title="Read more" >...</a>

cobertura congreso

June 8, 2016

Rio de Janeiro – June 8, 2016. &nbsp; SOLACI-SBHCI 2016, the largest meeting on Interventional Cardiology in Latin America started with more than 1500 attendees. After the opening, by Congress President Marcelo Josén de Carvalho Cantarelli, we honored Dr. José Eduardo Sousa, the first to perform a coronary catheterization in Brazil, 50 years ago. After<a href="https://solaci.org/en/2016/06/15/30743/" title="Read more" >...</a>

VII Latin American Symposium on Structural Cardiomyopathy

Do you need an update on Structural Cardiomyopathy? If so, clear your schedule from July 27 thru 29. We are hosting the 7th Latin American Symposium on Structural Cardiomyopathy, to be held at the Intercontinental Hotel in Cali, Colombia, organized by Angiografía de Occidente S.A. Featuring lectures of national and international relevance and the presence<a href="https://solaci.org/en/2016/05/27/vii-latin-american-symposium-on-structural-cardiomyopathy/" title="Read more" >...</a>

Incidence and clinical impact of post TAVI infective endocarditis

Original title:&nbsp;Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation.&nbsp;Reference:&nbsp;Manuel Mart&iacute;nez-Sell&eacute;s et al. &nbsp;EuroIntervention 2015;10-online publish-ahead-of-print February 2015. Prosthesis endocarditis is a complication with serious clinical consequences due to its high morbimortality. Infective endocarditis (IE) in TAVI has been described in few cases and, in cohort studies, it occurs within 0 to<a href="https://solaci.org/en/2015/03/13/n-5062/" title="Read more" >...</a>

Impact of kidney function on TAVI outcome

Original title:&nbsp;Impact of chronic kidney disease on the outcome of transcatheter aortic valve implantation: results from the FRANCE 2 Registry.&nbsp;Reference:&nbsp;Atsushi Oguri, et al. EuroIntervention 2015;10:e1-9 Globally, 13% of patients present kidney failure, which has been associated to a worse evolution not only of TAVI outcomes but also of other cardiovascular intervention outcomes. Most studies, including<a href="https://solaci.org/en/2015/02/19/n-4999/" title="Read more" >...</a>

Aortic insufficiency has a poor prognosis in TAVI.

Original title:&nbsp;Impact of Post-Procedural Aortic Regurgitation on Mortality Alter Trancatheter Aortic Valve Implantation&nbsp;Reference:&nbsp;Kentaro Hayashida, et al. J Am Coll Interv 2012;5:1247-56 Transcatheter aortic valve implantation (TAVI) sprung up as a valid strategy to treat patients with severe high risk AS (aortic stenosis). However, residual aortic regurgitation (post AR) and post-dilation remain unsolved.&nbsp; Between October 2006<a href="https://solaci.org/en/2013/01/15/n-3200/" title="Read more" >...</a>

Top